English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

After more than a decade of biomarker discovery research using advanced genomic and proteomic technologies, very few biomarkers have been translated into clinical diagnostics for patient care. This has become an urgent issue to be addressed because the continuing funding from both the public and private sources are called into question.

cancer epidemiology, biomarkers and prevention

The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared<i>In Vitro</i>Diagnostic Multivariate Index Assay of Proteomic Biomarkers

The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-ClearedIn VitroDiagnostic Multivariate Index Assay of Proteomic Biomarkers